SCHEMBL6766145

SCHEMBL6766145

CCCS(=O)(=O)NCC(C)c1ccc2cc(OCCNS(=O)(=O)C(F)(F)F)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 3/20 0.43
CNR1 P21554 2/20 0.38
HRAS P01112 1/20 0.37
KRAS P01116 1/20 0.37
SLC6A9 P48067 2/20 0.37
CYP17A1 P05093 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CA12 O43570 3/20 0.37
CA4 P22748 3/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
PTGS2 P35354 1/20 0.36
CYP3A4 P08684 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6759350 0.92 GRIA4 (0.47) GRIA4HRASKRASSLC6A9CA12
SCHEMBL6763807 0.87 ALDH1A1 (0.47) GRIA4HRASKRASSLC6A9CA12
SCHEMBL6766144 0.86 GRIA4 (0.45) GRIA4CNR1HRASKRASCYP17A1
SCHEMBL6765779 0.84 ALDH1A1 (0.52) GRIA4HRASKRASCA12CA1
SCHEMBL6763723 0.83 GRIA4 (0.53) GRIA4CA12CA1CA2CA9
SCHEMBL6573583 0.83 GRIA4 (0.48) GRIA4SLC6A9CA12CA4CA1
SCHEMBL6763719 0.82 ACACB (0.47) GRIA4CA12CA4CA1CA2
SCHEMBL6762961 0.81 KDM4E (0.44) GRIA4PTGS2LMNAHTTAKR1C3
SCHEMBL6763754 0.81 CA4 (0.44) GRIA4CA12CA4CA1CA2
SCHEMBL6761042 0.80 PPARG (0.55) GRIA4LMNAKDM4EPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 GRIA4 9/4885CNR1 62/4885HRAS 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.